Stanley Tam

Stanley Tam is a skilled professional in biotechnological research with extensive experience in vector and cell process development. Presently a Senior Associate Scientist at Obsidian Therapeutics since 2020, Stanley has previously contributed as a Senior Research Associate at Rubius Therapeutics, focusing on lentiviral vector engineering and non-viral gene delivery via transposons. Additionally, Stanley served as a Research Associate at Harvard Medical School from 2012 to 2017, specializing in high-throughput proteomic mapping using affinity-purification mass spectrometry. Stanley's educational background includes a Bachelor's Degree in Biology/Biological Sciences from the University at Albany.